
Harmony Biosciences Delivers Strong Q2 Growth, Advances Late-Stage Pipeline
PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) reported another quarter of double-digit revenue growth and solidified its position as a profitable, late-stage biotech leader, driven by continued momentum …
Harmony Biosciences Delivers Strong Q2 Growth, Advances Late-Stage Pipeline Read More